Skye Bioscience, Inc. Payments of Stock Issuance Costs
Skye Bioscience, Inc. (SKYE) reported Payments of Stock Issuance Costs of $6.43 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-03-10
- Skye Bioscience, Inc. payments of stock issuance costs for the quarter ending 2021-12-31 was $83.72K.
- Skye Bioscience, Inc. payments of stock issuance costs for the quarter ending 2020-12-31 was $0.00.
- Skye Bioscience, Inc. payments of stock issuance costs for the quarter ending 2020-09-30 was $854.08K.
- Skye Bioscience, Inc. payments of stock issuance costs for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- Skye Bioscience, Inc. payments of stock issuance costs for fiscal 2024 was $6.43M.
- Skye Bioscience, Inc. payments of stock issuance costs for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Skye Bioscience, Inc. payments of stock issuance costs for fiscal 2021 was $935.26K, a 9.51% increase from fiscal 2020.
- Skye Bioscience, Inc. payments of stock issuance costs for fiscal 2020 was $854.08K, a 9082.65% increase from fiscal 2019.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 9 month as first filed | Payments of Stock Issuance Costs 12 month | Payments of Stock Issuance Costs 12 month as first filed |
|---|---|---|---|---|---|---|
| 2024-12-31 | $6.43M 10-K · filed 2026-03-10 | |||||
| 2022-12-31 | $0.00 10-K · filed 2023-03-31 | |||||
| 2021-12-31 | $83.72K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $935.26K 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | $851.54K 10-Q · filed 2022-11-14 | |||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $854.08K derived: sum of 2 quarters · filed 2022-03-28 | $854.08K 10-K · filed 2022-03-28 | $0.00 10-K · filed 2021-03-02 | ||
| 2020-09-30 | $854.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $854.08K 10-Q · filed 2021-11-10 | $0.00 10-Q · filed 2020-11-06 | |||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-13 | |||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $0.00 derived: sum of 2 quarters · filed 2021-03-02 | $179.00 derived: sum of 3 quarters · filed 2021-03-02 | $9.30K 10-K · filed 2021-03-02 | $80.63K 10-K · filed 2020-03-23 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $179.00 derived: sum of 2 quarters · filed 2020-11-06 | $9.30K 10-Q · filed 2020-11-06 | $16.90K 10-Q · filed 2019-11-14 | $146.49K derived: sum of 4 quarters · filed 2020-11-06 | |
| 2019-06-30 | $179.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $9.30K 10-Q · filed 2020-08-13 | $146.49K derived: sum of 3 quarters · filed 2020-08-13 | $146.49K derived: sum of 4 quarters · filed 2020-08-13 | ||
| 2019-03-31 | $9.12K 10-Q · filed 2019-05-10 | $146.31K derived: sum of 2 quarters · filed 2020-03-23 | $146.31K derived: sum of 3 quarters · filed 2020-03-23 | |||
| 2018-12-31 | $137.19K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-23 | $137.19K derived: sum of 2 quarters · filed 2020-03-23 | $154.09K 10-K · filed 2020-03-23 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $16.90K 10-Q · filed 2018-11-14 | ||||
| 2018-06-30 | $16.90K 10-Q · filed 2019-08-09 | |||||
| 2017-03-31 | $183.34K 10-Q · filed 2018-05-15 | |||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $0.00 derived: sum of 2 quarters · filed 2017-03-10 | $0.00 derived: sum of 3 quarters · filed 2017-03-10 | $3.92K 10-K · filed 2017-03-10 | ||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $0.00 derived: sum of 2 quarters · filed 2016-08-12 | $3.92K 10-Q · filed 2015-11-12 | $8.10K derived: sum of 4 quarters · filed 2016-08-12 | ||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $3.92K 10-Q · filed 2016-08-12 | $8.10K derived: sum of 3 quarters · filed 2016-08-12 | |||
| 2015-03-31 | $3.92K 10-Q · filed 2016-05-13 | $8.10K derived: sum of 2 quarters · filed 2016-05-13 | ||||
| 2014-12-31 | $4.18K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-21 | $14.20K 10-K · filed 2016-03-21 | ||||
| 2014-09-30 | $10.02K 10-Q · filed 2014-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |